| scholarly article | Q13442814 |
| P50 | author | Adriana Haimovitz-Friedman | Q63367471 |
| P2093 | author name string | Jonathan L Tilly | |
| Patricia A Hunt | |||
| Richard Kolesnick | |||
| Zvi Fuks | |||
| Mousumi Bose | |||
| Hai Nguyen | |||
| William F Morgan | |||
| François Paris | |||
| Gloria I Perez | |||
| Arlene Ilagan | |||
| P2860 | cites work | Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy | Q28140319 |
| To err (meiotically) is human: the genesis of human aneuploidy | Q29618613 | ||
| Commuting the death sentence: how oocytes strive to survive | Q34443613 | ||
| The effects of radiotherapy and chemotherapy on female reproduction | Q34452333 | ||
| Stage specificity, dose response, and doubling dose for mouse minisatellite germ-line mutation induced by acute radiation | Q37393920 | ||
| Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. | Q48950370 | ||
| The micronucleus assay with mouse peripheral blood reticulocytes using acridine orange-coated slides | Q67678226 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 901-2 | |
| P577 | publication date | 2002-09-01 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | Sphingosine 1-phosphate preserves fertility in irradiated female mice without propagating genomic damage in offspring | |
| P478 | volume | 8 |
| Q36693839 | Acid sphingomyelinase involvement in tumor necrosis factor alpha-regulated vascular and steroid disruption during luteolysis in vivo |
| Q28481843 | Acute doxorubicin insult in the mouse ovary is cell- and follicle-type dependent |
| Q80962177 | Age is no barrier... |
| Q37430168 | Antiapoptotic agent sphingosine-1-phosphate protects vitrified murine ovarian grafts |
| Q35633883 | Ceramide-rich platforms in transmembrane signaling |
| Q37181877 | Characterization of the gonadotropin releasing hormone receptor (GnRHR) expression and activity in the female mouse ovary |
| Q38842887 | Chemotherapy-induced damage to ovary: mechanisms and clinical impact |
| Q28477444 | Chemotherapy-induced late transgenerational effects in mice |
| Q37091180 | Construction of conditional acid ceramidase knockout mice and in vivo effects on oocyte development and fertility |
| Q91938143 | Current state and future possibilities of ovarian tissue transplantation |
| Q27345163 | Dexrazoxane Diminishes Doxorubicin-Induced Acute Ovarian Damage and Preserves Ovarian Function and Fecundity in Mice |
| Q35201332 | Dexrazoxane abrogates acute doxorubicin toxicity in marmoset ovary |
| Q35862550 | Dexrazoxane ameliorates doxorubicin-induced injury in mouse ovarian cells |
| Q48684877 | Dose-dependent effect of sphingosine-1-phosphate in mouse oocyte maturation medium on subsequent embryo development. |
| Q64963880 | Female Fertility Preservation through Stem Cell-based Ovarian Tissue Reconstitution In Vitro and Ovarian Regeneration In Vivo. |
| Q93134519 | Fertility Preservation Using GnRH Agonists: Rationale, Possible Mechanisms, and Explanation of Controversy |
| Q90244041 | Fertility Preservation in Women With Malignancy: Future Endeavors |
| Q37932564 | Fertility sparing in cancer patients |
| Q37282095 | GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. |
| Q36901831 | Granulocyte colony-stimulating factor with or without stem cell factor extends time to premature ovarian insufficiency in female mice treated with alkylating chemotherapy. |
| Q33808022 | Growth-limiting role of endothelial cells in endoderm development |
| Q35539112 | Gynaecologic concerns for young women exposed to gonadotoxic chemotherapy |
| Q89660430 | History, Evolution and Current State of Ovarian Tissue Auto-Transplantation with Cryopreserved Tissue: a Successful Translational Research Journey from 1999 to 2020 |
| Q28267696 | How do chemotherapeutic agents damage the ovary? |
| Q38038330 | ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs--threshold doses for tissue reactions in a radiation protection context |
| Q24632632 | In vivo delivery of FTY720 prevents radiation-induced ovarian failure and infertility in adult female nonhuman primates |
| Q44697049 | Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition. |
| Q90366459 | Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide |
| Q35159150 | Intracellular mechanisms regulating cell survival in ovarian follicles |
| Q45246431 | Localization of sphingosine kinase-1 in mouse sperm acrosomes |
| Q37414484 | Lyase to live by: sphingosine phosphate lyase as a therapeutic target |
| Q37375507 | Membrane signaling induced by high doses of ionizing radiation in the endothelial compartment. Relevance in radiation toxicity |
| Q35664417 | Multiple approaches for individualized fertility protective therapy in cancer patients |
| Q39159757 | Nuclear phosphoinositide regulation of chromatin. |
| Q37381041 | Orthotopic and heterotopic ovarian tissue transplantation. |
| Q58116467 | Pharmacological inhibition or small interfering RNA targeting acid ceramidase sensitizes hepatoma cells to chemotherapy and reduces tumor growth in vivo |
| Q36341274 | Physiological and pathophysiological aspects of ceramide |
| Q35146936 | Pleiotropic actions of sphingosine-1-phosphate |
| Q47643316 | Preliminary experience of ovarian tissue cryopreservation procedure: alternatives, perspectives and feasibility. |
| Q33853424 | Premature ovarian aging in mice deficient for Gpr3. |
| Q28240178 | Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents |
| Q39456838 | Prolonging Reproductive Life after Cancer: The Need for Fertoprotective Therapies |
| Q44653171 | Protection from Radiation-Induced Male Germ Cell Loss by Sphingosine-1-Phosphate1 |
| Q34559806 | Regulating survival and development in the retina: key roles for simple sphingolipids |
| Q34879183 | Roles of sphingosine 1-phosphate on tumorigenesis |
| Q37699303 | Roles of sphingosine-1-phosphate in reproduction |
| Q35006026 | S1P lyase regulates DNA damage responses through a novel sphingolipid feedback mechanism. |
| Q38208378 | Sexual and fertility adverse effects associated with chemotherapy treatment in women |
| Q35675184 | Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond |
| Q34530525 | Sphingolipids, apoptosis, cancer treatments and the ovary: investigating a crime against female fertility |
| Q35206936 | Sphingosine 1-phosphate pathway therapeutics: a lipid ligand-receptor paradigm |
| Q45022818 | Sphingosine 1-phosphate protects bovine oocytes from heat shock during maturation |
| Q51104639 | Sphingosine-1-phosphate activates the AKT pathway to inhibit chemotherapy induced human granulosa cell apoptosis. |
| Q36145233 | Sphingosine-1-phosphate lyase expression in embryonic and adult murine tissues |
| Q37192698 | Sphingosine-1-phosphate lyase in development and disease: sphingolipid metabolism takes flight |
| Q37387475 | Sphingosine-1-phosphate prevents chemotherapy-induced human primordial follicle death |
| Q36574777 | Supplementation of transport and freezing media with anti-apoptotic drugs improves ovarian cortex survival |
| Q47579813 | The Impact of a Long-Acting Oral Sphingosine-1-Phosphate Analogue on Ovarian Aging in a Rat Model |
| Q38096833 | Using ASMase knockout mice to model human diseases |
Search more.